DeepMed Research

Population Health Research Institute

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 251

Market Cap: -

Website: http://www.phri.ca

Clinical Trials

Higher vs. Lower Dose Heparin for PCI

Not Applicable

Recruiting

Conditions: Cardiovascular Diseases
Percutaneous Coronary Intervention

Interventions: Drug: Higher Dose UFH
Drug: Lower Dose UFH

First Posted Date: 2019-08-08

Last Posted Date: 2024-06-20

Lead Sponsor: Population Health Research Institute

Target Recruit Count: 16000

Registration Number: NCT04049591

Locations: 🇨🇦
Hamilton Health Sciences, General Hospital, Hamilton, Ontario, Canada

Living Green and Healthy for Teens

Not Applicable

Active, not recruiting

Conditions: Healthy Lifestyle
Adolescent Behavior

Interventions: Behavioral: Aim2Be smartphone app system
Behavioral: BnLt smartphone app

First Posted Date: 2019-06-24

Last Posted Date: 2025-03-27

Lead Sponsor: Population Health Research Institute

Target Recruit Count: 74

Registration Number: NCT03996109

Locations: 🇨🇦
Hamilton Health Sciences, Hamilton, Ontario, Canada

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Perioperative AF After Noncardiac Surgery

Phase 4

Recruiting

Conditions: Stroke
Atrial Fibrillation

Interventions: Drug: Non-vitamin K oral anticoagulant (NOAC)

First Posted Date: 2019-05-30

Last Posted Date: 2025-05-11

Lead Sponsor: Population Health Research Institute

Target Recruit Count: 2270

Registration Number: NCT03968393

Locations: 🇦🇺
Box Hill Hospital, Box Hill, Victoria, Australia
🇳🇱
Rijnstate Hospital, Arnhem, Netherlands
🇳🇿
Dunedin Public Hospital, Dunedin, New Zealand

and more 87 locations

DEPOSITION - Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery

Phase 3

Terminated

Conditions: Bleeding
Surgical Blood Loss
Seizures

Interventions: Drug: Tranexamic Acid

First Posted Date: 2019-05-17

Last Posted Date: 2023-12-08

Lead Sponsor: Population Health Research Institute

Target Recruit Count: 3242

Registration Number: NCT03954314

Locations: 🇨🇦
Kelowna General Hospital, Kelowna, British Columbia, Canada
🇨🇦
Hamilton Health Sciences - General Hospital, Hamilton, Ontario, Canada
🇨🇦
St. Boniface Hospital, Winnipeg, Manitoba, Canada

and more 13 locations

EdoxabaN for IntraCranial Hemorrhage Survivors with Atrial Fibrillation (ENRICH-AF)

Phase 4

Active, not recruiting

Conditions: Intracranial Hemorrhages
Atrial Fibrillation

Interventions: Other: Non-anticoagulant medical therapy
Drug: Edoxaban

First Posted Date: 2019-05-15

Last Posted Date: 2025-01-16

Lead Sponsor: Population Health Research Institute

Target Recruit Count: 948

Registration Number: NCT03950076

Locations: 🇺🇸
Alexian Brothers Medical Center, Elk Grove Village, Illinois, United States
🇺🇸
Presence Care Transformation Corporation, Lisle, Illinois, United States
🇺🇸
Tulane University Medical Center, New Orleans, Louisiana, United States

and more 149 locations

Benzodiazepine-free Cardiac Anesthesia for Reduction of Postoperative Delirium

Not Applicable

Active, not recruiting

Conditions: Post-cardiac Surgery
Delirium

Interventions: Other: Liberal Intraoperative Benzodiazepine
Other: Limited Intraoperative Benzodiazepine

First Posted Date: 2019-04-26

Last Posted Date: 2025-03-04

Lead Sponsor: Population Health Research Institute

Target Recruit Count: 15886

Registration Number: NCT03928236

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States
🇺🇸
Weill Cornell Medicine, New York, New York, United States
🇨🇦
Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada

and more 17 locations

Ross for Valve Replacement in Adults - Registry

Completed

Conditions: Aortic Valve Disease

First Posted Date: 2019-03-29

Last Posted Date: 2024-01-31

Lead Sponsor: Population Health Research Institute

Target Recruit Count: 62

Registration Number: NCT03894787

Locations: 🇨🇦
Hamilton General Hospital, Hamilton, Ontario, Canada

Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira

Phase 3

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: IDegLira
Drug: insulin degludec
Drug: Metformin
Behavioral: Lifestyle Therapy

First Posted Date: 2019-03-05

Last Posted Date: 2023-10-25

Lead Sponsor: Population Health Research Institute

Target Recruit Count: 159

Registration Number: NCT03862716

Locations: 🇨🇦
University of Alberta, Edmonton, Alberta, Canada
🇨🇦
McMaster University, Hamilton, Ontario, Canada
🇨🇦
Western University, London, Ontario, Canada

and more 5 locations

Remote ECG Monitoring of TAVI Patients

Not Applicable

Conditions: Cardiac Valve Disease
Aortic Valve Stenosis

Interventions: Device: mobile Cardiac Arrhythmia Diagnostics Service (m-CARDS)

First Posted Date: 2019-01-22

Last Posted Date: 2021-02-04

Lead Sponsor: Population Health Research Institute

Target Recruit Count: 240

Registration Number: NCT03810820

Locations: 🇨🇦
Hamilton Health Sciences Corporation - Hamilton General Hospital, Hamilton, Ontario, Canada

DIalysis Symptom COntrol-Restless Legs Syndrome Trial

Phase 3

Completed

Conditions: Restless Legs Syndrome
End Stage Renal Disease

Interventions: Drug: Ropinirole
Drug: Gabapentin
Drug: Placebo Ropinirole
Drug: Placebo Gabapentin

First Posted Date: 2019-01-16

Last Posted Date: 2022-09-21

Lead Sponsor: Population Health Research Institute

Target Recruit Count: 52

Registration Number: NCT03806530

Locations: 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada
🇨🇦
St. Joseph's Hamilton Healthcare, Hamilton, Ontario, Canada
🇨🇦
Nova Scotia Health Authority, Halifax, Nova Scotia, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy